Current developments in nutrition · 2026
Associations between Red Blood Cell Folate Forms and Demographic, Physiologic, and Lifestyle Factors in the United States Population: Cross-Sectional Data from the National Health and Nutrition Examination Survey August 2021-August 2023.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fazili Zia, Pfeiffer Christine M, Sternberg Maya R, Ngac Phuong, Zhang Ming, Crider Krista S, Leachman Jacqueline, Williams Anne, Gahche Jaime J, Paladugula Neelima, Hong Kelly, Fischer Christina
Аннотация
BACKGROUND: Red blood cell (RBC) total folate (TFOL) is an indicator of long-term folate status. Data on RBC folate forms are lacking. They may inform associations with health-related indicators.
OBJECTIVES: We aimed to describe associations between RBC folate forms and different factors in the United States population.
METHODS: We used data for 5 biologically active RBC folate forms [5-methyltetrahydrofolate (5-methylTHF), unmetabolized folic acid (UMFA), tetrahydrofolate (THF), 5-formyltetrahydrofolate (5-formylTHF), and 5,10-methenyltetrahydrofolate (5,10-methenylTHF); sum of which is TFOL] and 1 oxidation product of 5-methylTHF (MeFox) in persons aged ≥6 y participating in the National Health and Nutrition Examination Survey 2021-2023 cycle. We excluded pregnant or lactating females. We assessed bivariate associations between folate biomarkers [concentrations for TFOL, 5-methylTHF, THF, and MeFox; prevalences ≥limit of detection (LOD) for UMFA, 5-formylTHF, and 5,10-methenylTHF] and demographic, physiologic, and lifestyle variables in persons ≥20 y, accounting for the complex sample design. We estimated the impact of covariates on biomarker concentrations or odds ratios after covariate adjustment.
RESULTS: In persons ≥6 y (n=7126), geometric mean concentrations (nmol/L) were 913 (TFOL), 835 (5-methylTHF), 26.3 (THF), and 161 (MeFox); prevalences ≥LOD (%) were 43.6 (UMFA), 40.6 (5-formylTHF), and 73.0 (5,10-methenylTHF); and contributions to RBC TFOL were 92.7% (5-methylTHF), 5.02% (THF), and 1.61% (5,10-methenylTHF), varying by race/Hispanic origin. In persons ≥20 y, fasting status was not associated with biomarker concentrations or the prevalence ≥LOD. Biomarkers were significantly associated before and after covariate adjustment with age (TFOL; 5-methylTHF; THF; 5,10-methenylTHF), sex (MeFox), race/Hispanic origin (TFOL; 5-methylTHF; THF; MeFox), body mass index (TFOL; 5-methylTHF), tobacco use (TFOL; THF; MeFox), and folic acid supplement use (TFOL; 5-methylTHF; THF; MeFox; 5-formylTHF; 5,10-methenylTHF). Covariates explained ≤21% of the variation of 5-methylTHF, THF, or MeFox concentrations.
CONCLUSIONS: Folic acid supplement use was the strongest predictor of RBC folate biomarker concentrations and detection. Differences in the methyl-to-nonmethyl makeup of RBC TFOL by race/Hispanic origin suggest potential biological and/or genetic influences.
OBJECTIVES: We aimed to describe associations between RBC folate forms and different factors in the United States population.
METHODS: We used data for 5 biologically active RBC folate forms [5-methyltetrahydrofolate (5-methylTHF), unmetabolized folic acid (UMFA), tetrahydrofolate (THF), 5-formyltetrahydrofolate (5-formylTHF), and 5,10-methenyltetrahydrofolate (5,10-methenylTHF); sum of which is TFOL] and 1 oxidation product of 5-methylTHF (MeFox) in persons aged ≥6 y participating in the National Health and Nutrition Examination Survey 2021-2023 cycle. We excluded pregnant or lactating females. We assessed bivariate associations between folate biomarkers [concentrations for TFOL, 5-methylTHF, THF, and MeFox; prevalences ≥limit of detection (LOD) for UMFA, 5-formylTHF, and 5,10-methenylTHF] and demographic, physiologic, and lifestyle variables in persons ≥20 y, accounting for the complex sample design. We estimated the impact of covariates on biomarker concentrations or odds ratios after covariate adjustment.
RESULTS: In persons ≥6 y (n=7126), geometric mean concentrations (nmol/L) were 913 (TFOL), 835 (5-methylTHF), 26.3 (THF), and 161 (MeFox); prevalences ≥LOD (%) were 43.6 (UMFA), 40.6 (5-formylTHF), and 73.0 (5,10-methenylTHF); and contributions to RBC TFOL were 92.7% (5-methylTHF), 5.02% (THF), and 1.61% (5,10-methenylTHF), varying by race/Hispanic origin. In persons ≥20 y, fasting status was not associated with biomarker concentrations or the prevalence ≥LOD. Biomarkers were significantly associated before and after covariate adjustment with age (TFOL; 5-methylTHF; THF; 5,10-methenylTHF), sex (MeFox), race/Hispanic origin (TFOL; 5-methylTHF; THF; MeFox), body mass index (TFOL; 5-methylTHF), tobacco use (TFOL; THF; MeFox), and folic acid supplement use (TFOL; 5-methylTHF; THF; MeFox; 5-formylTHF; 5,10-methenylTHF). Covariates explained ≤21% of the variation of 5-methylTHF, THF, or MeFox concentrations.
CONCLUSIONS: Folic acid supplement use was the strongest predictor of RBC folate biomarker concentrations and detection. Differences in the methyl-to-nonmethyl makeup of RBC TFOL by race/Hispanic origin suggest potential biological and/or genetic influences.